Regulation of Monocyte IL-10 Synthesis by Endogenous IL-1 and TNF-alpha: Role of the P38 and P42/44 Mitogen-activated Protein Kinases
Overview
Affiliations
IL-10 is an anti-inflammatory cytokine with potent immunomodulatory effects, including inhibition of cytokine production. However, regulation of monocyte IL-10 production is poorly understood. In this report we have investigated the mechanisms of LPS-induced IL-10 production by human peripheral blood monocytes and demonstrate that IL-10 synthesis is uniquely dependent on the endogenous proinflammatory cytokines IL-1 and/or TNF-alpha. LPS signal transduction in monocytes has been shown to involve activation of the p38 and p42 mitogen-activated protein kinase (MAPK) cascades. The results in this paper indicate that inhibition of p38 MAPK potently inhibited the production of IL-10, IL-1beta, and TNF-alpha, whereas blockade of the p42/44 MAPK pathway, while partially inhibiting TNF-alpha and IL-1beta production, had no effect on monocyte secretion of IL-10. Furthermore, neither the inhibition of monocyte TNF-alpha induced by IL-10 nor the stimulation of soluble TNF receptor production was affected by inhibition of the p42/44 MAPK pathway, suggesting that this signaling event is not involved in either monocyte production of or anti-inflammatory responses to IL-10. These data raise the interesting possibility that proinflammatory TNF-alpha-mediated effects may be selectively blocked without modulating the induction or the response to IL-10, whereas the signaling events associated with the anti-inflammatory events induced by IL-10 remain to be elucidated.
Metabolic reprogramming of macrophages by PKM2 promotes IL-10 production via adenosine.
Toller-Kawahisa J, Viacava P, Palsson-McDermott E, Nascimento D, Cervantes-Silva M, OCarroll S Cell Rep. 2025; 44(1):115172.
PMID: 39772395 PMC: 11781862. DOI: 10.1016/j.celrep.2024.115172.
Jo H, Kim H Cell Biochem Biophys. 2024; 82(2):919-925.
PMID: 38480573 PMC: 11344723. DOI: 10.1007/s12013-024-01243-7.
Pharmacogenomic and epigenomic approaches to untangle the enigma of IL-10 blockade in oncology.
Elemam N, Mekky R, Rashid G, Braoudaki M, Youness R Expert Rev Mol Med. 2024; 26:e1.
PMID: 38186186 PMC: 10941350. DOI: 10.1017/erm.2023.26.
Ruffaner-Hanson C, Fernandez-Oropeza A, Sun M, Caldwell K, Allan A, Savage D Front Neurosci. 2023; 17:1203557.
PMID: 37425005 PMC: 10326286. DOI: 10.3389/fnins.2023.1203557.
Shnayder N, Ashkhotov A, Trefilova V, Nurgaliev Z, Novitsky M, Petrova M Int J Mol Sci. 2023; 24(9).
PMID: 37175399 PMC: 10178334. DOI: 10.3390/ijms24097692.